The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
A randomized phase III trial of S-1/oxaliplatin (SOX) versus UFT/leucovorin as adjuvant chemotherapy for high-risk stage III colon cancer: The ACTS-CC 02 trial.
 
Takao Takahashi
Honoraria - Taiho Pharmaceutical; Yakult Honsha
 
Eiji Sunami
No Relationships to Disclose
 
Tetsuya Kusumoto
No Relationships to Disclose
 
Mitsuyoshi Ota
No Relationships to Disclose
 
Yoshiyuki Sakamoto
No Relationships to Disclose
 
Naohiro Tomita
Research Funding - Chugai Pharma (Inst); Taiho Pharmaceutical (Inst)
 
Atsuyuki Maeda
No Relationships to Disclose
 
Jin Tejima
No Relationships to Disclose
 
Michio Okabe
No Relationships to Disclose
 
Chihiro Tanaka
No Relationships to Disclose
 
Junichiro Yamauchi
No Relationships to Disclose
 
Michio Itabashi
Speakers' Bureau - Bayer Yakuhin
Research Funding - Chugai Pharma (Inst); Takeda (Inst)
 
Kenjiro Kotake
No Relationships to Disclose
 
Keiichi Takahashi
Honoraria - Chugai Pharma; Taiho Pharmaceutical; Takeda
 
Hideo Baba
Honoraria - Lilly; Ono Pharmaceutical; Taiho Pharmaceutical
Research Funding - Chugai Pharma (Inst); Lilly (Inst); Merck Serono (Inst); Taiho Pharmaceutical (Inst); Yakult Honsha (Inst)
 
Narikazu Boku
Honoraria - Bristol-Myers Squibb Japan; Chugai Pharma; Lilly Japan; Ono Pharmaceutical; Taiho Pharmaceutical
Research Funding - Bristol-Myers Squibb (Inst); Ono Pharmaceutical (Inst); Taiho Pharmaceutical (Inst)
 
Keisuke Aiba
No Relationships to Disclose
 
Megumi Ishiguro
Honoraria - Merck Serono; Taiho Pharmaceutical; Yakult Honsha
Consulting or Advisory Role - Taiho Pharmaceutical
Research Funding - Taiho Pharmaceutical (Inst); Yakult Honsha (Inst)
 
Satoshi Morita
Honoraria - Bristol-Myers Squibb; Chugai Pharma; Taiho Pharmaceutical; Yakult Honsha
 
Kenichi Sugihara
Honoraria - Chugai Pharma; Taiho Pharmaceutical
Research Funding - Chugai Pharma (Inst); Taiho Pharmaceutical (Inst)